| Bone marrow stromal cell–derived exosomes as communicators in drug resistance in multiple myeloma cells J Wang, A Hendrix, S Hernot, M Lemaire, E De Bruyne, ... Blood, The Journal of the American Society of Hematology 124 (4), 555-566, 2014 | 441 | 2014 |
| Phase I study of 68Ga-HER2-nanobody for PET/CT assessment of HER2 expression in breast carcinoma M Keyaerts, C Xavier, J Heemskerk, N Devoogdt, H Everaert, C Ackaert, ... Journal of Nuclear Medicine 57 (1), 27-33, 2016 | 386 | 2016 |
| Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer I Vaneycken, N Devoogdt, N Van Gassen, C Vincke, C Xavier, U Wernery, ... The FASEB Journal 25 (7), 2433-2446, 2011 | 341 | 2011 |
| Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages K Movahedi, S Schoonooghe, D Laoui, I Houbracken, W Waelput, ... Cancer research 72 (16), 4165-4177, 2012 | 318 | 2012 |
| Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT LOT Gainkam, L Huang, V Caveliers, M Keyaerts, S Hernot, I Vaneycken, ... Journal of Nuclear Medicine 49 (5), 788-795, 2008 | 274 | 2008 |
| SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression L Huang, LOT Gainkam, V Caveliers, C Vanhove, M Keyaerts, ... Molecular imaging and biology 10, 167-175, 2008 | 240 | 2008 |
| Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer C Xavier, I Vaneycken, M D’huyvetter, J Heemskerk, M Keyaerts, C Vincke, ... Journal of Nuclear Medicine 54 (5), 776-784, 2013 | 225 | 2013 |
| Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions A Broisat, S Hernot, J Toczek, J De Vos, LM Riou, S Martin, M Ahmadi, ... Circulation research 110 (7), 927-937, 2012 | 225 | 2012 |
| Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody M D'Huyvetter, C Vincke, C Xavier, A Aerts, N Impens, S Baatout, ... Theranostics 4 (7), 708, 2014 | 206 | 2014 |
| Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS) AJ Einstein, TNB Pascual, M Mercuri, G Karthikeyan, JV Vitola, ... European heart journal 36 (26), 1689-1696, 2015 | 200 | 2015 |
| Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin M Brom, W Woliner-Van Der Weg, L Joosten, C Frielink, T Bouckenooghe, ... Diabetologia 57, 950-959, 2014 | 168 | 2014 |
| Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging S Massa, C Xavier, J De Vos, V Caveliers, T Lahoutte, S Muyldermans, ... Bioconjugate chemistry 25 (5), 979-988, 2014 | 165 | 2014 |
| Immuno-imaging using nanobodies I Vaneycken, M D’huyvetter, S Hernot, J De Vos, C Xavier, N Devoogdt, ... Current Opinion in Biotechnology 22 (6), 877-881, 2011 | 160 | 2011 |
| Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle Y Dekempeneer, M Keyaerts, A Krasniqi, J Puttemans, S Muyldermans, ... Expert opinion on biological therapy 16 (8), 1035-1047, 2016 | 155 | 2016 |
| In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT I Vaneycken, J Govaert, C Vincke, V Caveliers, T Lahoutte, ... Journal of Nuclear Medicine 51 (7), 1099-1106, 2010 | 148 | 2010 |
| 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment M D'Huyvetter, J De Vos, C Xavier, M Pruszynski, YGJ Sterckx, S Massa, ... Clinical cancer research 23 (21), 6616-6628, 2017 | 147 | 2017 |
| PET imaging of macrophage mannose receptor–expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments A Blykers, S Schoonooghe, C Xavier, K D’hoe, D Laoui, M D’Huyvetter, ... Journal of Nuclear Medicine 56 (8), 1265-1271, 2015 | 147 | 2015 |
| Localization, mechanism and reduction of renal retention of technetium‐99m labeled epidermal growth factor receptor‐specific nanobody in mice LO Tchouate Gainkam, V Caveliers, N Devoogdt, C Vanhove, C Xavier, ... Contrast media & molecular imaging 6 (2), 85-92, 2011 | 143 | 2011 |
| Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target J De Vos, N Devoogdt, T Lahoutte, S Muyldermans Expert opinion on biological therapy 13 (8), 1149-1160, 2013 | 142 | 2013 |
| Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours P Debie, C Lafont, M Defrise, I Hansen, DM van Willigen, ... Journal of controlled release 317, 34-42, 2020 | 140 | 2020 |
